AKT1 and esophageal squamous cell carcinoma: Similarly, in esophageal squamous cell carcinoma (ESCC), C/EBPγ promotes proliferation and migration through the upregulation of the PI3K-Akt signaling pathway and serves as a prognostic marker for poor survival [31].